Abstract
Interstitial Cystitis (IC) is a chronic disease of unknown etiology which primarily affects women aged 40–60 years. Many plausible theories for the development of IC have been postulated, and one current theory is that these patients have a quantitative and qualitative defect in the glycosaminoglycan (GAG) layer of the urothelium. Such a defect may allow toxic substances in the urine to gain access to the lamina propria and initiate a chronic inflammatory process. Pentosanpolysulphate (PPS) is a sulphated proteoglycan similar in structure to heparin sulphate, which is quantitatively the major GAG on cell surfaces. Exogenously administered PPS has been shown in several studies to decrease bladder pain and urinary frequency and to increase the voided volume. Further studies are required to evaluate the role of PPS in the management of IC patients, with particular emphasis on dosage, route of administration and combination with other compounds.
Similar content being viewed by others
References
Nietze M. Lehrbuch de kystosskopie: Ihre lechnik und klinische bedeutung. Berlin: JE Bergman, 1907;410
Hunner GL. A rare type of bladder ulcer in women: report of cases.Boston Med Surg J 1915;172:660–664
Walsh A. Interstitial cystitis. In: Hanson JH, Gittes RF, Perlmutter AD, Stamey TA, Walsh PC, eds. Campbell’s urology, 4th edn. Philadelphia: WB Saunders, 1978;693–707
Oravisto KJ. Epidemiology of interstitial cystitis.Ann Chir Gynaecol 1975;64:75
Hanno P, Wein A, Pauly M, Held P. Epidemiology and serial cost of interstital cystitis.J Urol 1988;139–176
De Juana CP, Everett JC. Interstitial cystitis, experience and review of recent literature.Urology 1977;10:325–329
Koziol JC, Clark DC, Gittes RF, Tan EM. The natural history of interstitial cystitis: a survey of 374 patients.J Urol 1993;143:465–469
Messing EM, Stamey TA. Interstitial cystitis, early diagnosis, pathology and treatment.Urology 1978;12:381–392
Holm-Bentzen M, Jacobsen F, Nerstrom B et al. A prospective double-blind clinically controlled multicenter trial of Elmiron (sulphopentosan sodium) in the treatment of interstitial cystitis and related painful bladder diseases.J Urol 1987;137:503–507
Holm-Bentzen M, Lose G. Pathology and pathogenesis of interstitial cystitis.Urology 1987;29:8–13
Messing EM. Interstitial cystitis and related syndromes. In: Walsh PC, Retik AB, Stamey TA, Vaughan ED, eds. Campbell’s urology, 5th edn. Philadelphia: WB Saunders, 1992;982–1006
Dixon JS, Gosling JA. The anatomy of the bladder, urethra and pelvic floor. In: Mundy AR, Stephenson TP, Wein AJ, eds. Urodynamics. Principles, practice and application, 2nd edn. Edinburgh: Churchill Livingstone, 1994;3–14
Parsons CL, Boychuk D, Jones S, Hurst R, Callahan H. Bladder surface glycosaminoglycans: an epithelial permeability barrier.J Urol 1990;143:139–142
Gregor HP. Anticoagulant activity of sulfonate polymers and copolymers. In: Gregor HP, ed. Polymer sciences and technology. New York: Plenum Press, 1975;5–56
Gregor HP. Fixed-charge ultrafiltration membranes. In: Selegny E. Charged gels and membranes. Amsterdam: D Reidel, 1976;235
Gryte CC, Gregor HP. Poly-(styrene sulfonic acid)-(vinyl-lidene fluoride) interpolymer ion-exchange membranes.Polym Sci 1976;14:1839
Parsons CL, Greenspan C, Moore SW, Mullholland SG. Role of surface mucin in primary antibacterial defence of bladder.Urology 1977;9:3:48–55
Dixon JS, Holm-Bentzen M, Gilpin CJ et al. Electron microscopic investigation of the bladder urothelium and glycocalyx in patients with interstitial cystitis.J Urol 1986;135:621–625
Eldrup J, Thorup J, Nielson SL, Hald T, Hainau B. Permeability and ultrastructure of human bladder epithelium.Br J Urol 1983;55:488–492
Lepinard V, Saint-Andre JP, Rogan LM. La Cystite intestitielle.J d’Urol 1984;90:455–465
Fowler JE, Lau JLT, Ghosh L, Mounze A, Lynes WL. Interstitial cystitis is associated with intraurothelial Tamm-Horsfall protein.J Urol 1988;139:276
Holm-Bentzen M, Ammitzball T, Hald T. Glycosaminoglycans on the surface of the human urothelium: a preliminary report.Neurourol Urodyn 1986;5:519–523
Sant GR, Ucci AA, Alroy J. Bladder glycosaminoglycans (GAGs) in interstitial cystitis.J Urol 1986;135:175
Comper WD, Laurent TC. Physiological function of connective tissue polysaccharides.Physiol Rev 1978;58:225–316
Jacques LB. Heparins — anionic polyelectrolyte drugs.Pharmacol Rev 1980;31:99–104
Weaver RG. Dougherty TF, Natolic CA. Recent concepts of interstitial cystitis.J Urol 1963;89:377–380
Lose G, Jespersen J, Frandsen B, Hojensgaard JC, Astrup T. Subcutaneous heparin in the treatment of interstitial cystitis.Scand J Urol Nephrol 1985;19:27–29
Barrington JW, Fraylin L, Fish R, Shelley M, Stephenson TP. Elevated levels of basic fibroblast growth factor in the urine of clam enterocystoplasty patients.J Urol 1996;155:468–470
Barrington JW, Fulford S, Fraylin L, Fish R, Shelley M, Stephenson TP. The use of pentosan polysulphate sodium to reduce urinary basic fibroblast growth factor in clam enterocystoplasty patients.Br J Urol 1996;78:54–56
Toozs-Hobson P, Gleeson C, Cardoza L. Interstitial cystitis — still an enigma after 80 years.Br J Obstet Gynaecol 1996;193:621–624
Parsons CL, Mulholland SG. Successful therapy of interstitial cystitis with pentosanpolysulfate sodium.J Urol 1987;138:513–516
Mulholland SG, Hanno P, Parsons CL, Sant GR, Staskin DR. Pentosanpolysulfate sodium for therapy of interstitial cystitis. A double-blind placebo-controlled clinical study.Urology 1990;135:552–558
Fritjofsson QA, Fall M, Juhlin R, Persson BE, Ruutu M. Treatment of ulcer and nonulcer interstitial cystitis with sodium pentosanpolysulfate: a multicenter trial.J Urol 1987;138:508–512
Parsons CL, Benson G, Childs SJ, Hanno P, Sant GR, Webster G. A quantitatively controlled method to study prospectively interstitial cystitis and demonstrate the efficacy of pentosanpoly-sulfate.J Urol 1993;150:845–848
Perez-Marrero R, Emerson LE, Maharajh DO. Prolongation of response to DMSO by heparin maintenance.Urology 1993;41:64.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Barrington, J.W., Stephenson, T.P. Pentosanpolysulphate for interstitial cystitis. Int Urogynecol J 8, 293–295 (1997). https://doi.org/10.1007/BF02765487
Issue Date:
DOI: https://doi.org/10.1007/BF02765487